|
1st
Quarter 2006 Revised Update: Oral Anticancer Drug Fees
The fees listed below are effective January 1, 2006, through March 31, 2006.
Inclusion or exclusion of a fee schedule amount for an item or service
does not imply any health insurance coverage.
|
Drug
Name
|
Strength
|
Per
Tablet Fee
|
|
Busulfan
|
2 mg
|
$1.969
|
|
Capecitabine
|
150 mg
|
$3.638
|
|
Capecitabine
|
500 mg
|
$12.086
|
|
Cyclophosphamide
|
25 mg
|
$0.958
|
|
Cyclophosphamide
|
50 mg
|
$1.916
|
|
Etoposide
|
50 mg
|
$32.168
|
|
Melphalan
|
2 mg
|
$4.336
|
|
Methotrexate
|
2.5 mg
|
$0.281
|
|
Methotrexate
|
5 mg
|
$0.562
|
|
Methotrexate
|
7.5 mg
|
$0.843
|
|
Methotrexate
|
10 mg
|
$1.124
|
|
Methotrexate
|
15 mg
|
$1.686
|
|
Temozolomide
|
5 mg
|
$7.226
|
|
Temozolomide
|
20 mg
|
$28.904
|
|
Temozolomide
|
100 mg
|
$144.520
|
|
Temozolomide
|
250 mg
|
$361.300
|
9/07/06
|